|
About Anti-Thrombogenic
Polymer which Improves Artificial Kidney Performance
Tokyo-based Toray Industries Inc.
has received this year’s prestigious Ichimura Prize in Industry
for Excellent Achievement for its development and
commercialization of an anti-thrombogenic artificial kidney.
Drawing on the core nanotechnology
and computational chemistry capabilities to create an artificial
kidney from a polysulphone membrane that enhances anti-thrombogenic
performance in line with advances in dialysis treatment, a
Tokyo-based Toray Industries Inc. has developed and commercialized
an anti-thrombogenic artificial kidney. It has received this
year’s prestigious Ichimura Prize in Industry for the Excellent
Achievement.
Artificial kidneys remove waste products from the blood of renal
patients. Dialyzers incorporate polysulphone blended with
hydrophilic polyvinylpyrrolidone to achieve antithrombogenic
properties. To improve their performance, Toray applied a
proprietary hypothesis focused on how adsorbed water interacts
with polymers using computational chemistry in the polymer design
process. The research led to the discovery of a new anti-thrombogenic
polymer that can suppress platelet adhesion better than
polyvinylpyrrolidone. Toray went on to develop and commercialize
artificial kidneys for chronic and acute renal failure based on
this technology.
The technology helps improve the
quality of life of patients with chronic and acute renal failure
while reducing the workload of medical professionals.
The technology has been applied to a
number of products that enhance the patient’s quality of life and
clinical efficiency, including hemodialyzer, Toraylight HDF and
Toraysulfone NV hemodialysis filters which provides continuous and
gentle haemofiltration.
(
https://www.plasticstoday.com/medical/anti-thrombogenic-polymerimproves-artificial-kidney-performance,
Apr 18, 2022 )
* * * * *
|
